{"id":119790,"date":"2025-08-30T02:03:31","date_gmt":"2025-08-30T02:03:31","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/119790\/"},"modified":"2025-08-30T02:03:31","modified_gmt":"2025-08-30T02:03:31","slug":"genetic-analysis-second-quarter-2025-earnings-kr0-014-loss-per-share-vs-kr0-11-loss-in-2q-2024","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/119790\/","title":{"rendered":"Genetic Analysis Second Quarter 2025 Earnings: kr0.014 loss per share (vs kr0.11 loss in 2Q 2024)"},"content":{"rendered":"<p>Genetic Analysis (<a target=\"_blank\" href=\"https:\/\/simplywall.st\/stocks\/de\/pharmaceuticals-biotech\/fra-8v8\/genetic-analysis-shares\" rel=\"noopener noreferrer nofollow\" data-vars-link-type=\"intro\" class=\"company-report-links\">FRA:8V8<\/a>) Second Quarter 2025 ResultsKey Financial Results Revenue: kr7.15m (up 44% from 2Q 2024). Net loss: kr951.0k (loss narrowed by 80% from 2Q 2024). kr0.014 loss per share (improved from kr0.11 loss in 2Q 2024). <\/p>\n<p class=\"link-injector\"><a target=\"_blank\" href=\"https:\/\/simplywall.st\/discover\/investing-ideas\/282\/quantum-computing-stocks\/global\" rel=\"noopener noreferrer nofollow\" data-vars-link-type=\"investing-ideas\" class=\"company-report-links\">This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.<\/a><\/p>\n<p> <a target=\"_blank\" href=\"https:\/\/simplywall.st\/stocks\/de\/pharmaceuticals-biotech\/fra-8v8\/genetic-analysis-shares\/past\" rel=\"noopener noreferrer nofollow\" data-vars-link-type=\"infographic\" class=\"company-report-links\"><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/08\/1756443575051.png\" alt=\"earnings-and-revenue-history\" width=\"1642\" height=\"1120\" loading=\"lazy\" class=\"sc-8e1a88f-0 jKVhTH\"\/><\/a>DB:8V8 Earnings and Revenue History August 29th 2025 <\/p>\n<p>All figures shown in the chart above are for the trailing 12 month (TTM) period<\/p>\n<p> Genetic Analysis shares are up 17% from a week ago.  <\/p>\n<p> Risk Analysis<\/p>\n<p> It&#8217;s necessary to consider the ever-present spectre of investment risk. <a target=\"_blank\" href=\"https:\/\/simplywall.st\/stocks\/de\/pharmaceuticals-biotech\/fra-8v8\/genetic-analysis-shares\" rel=\"noopener noreferrer nofollow\" data-vars-link-type=\"conclusion\" class=\"company-report-links\">  We&#8217;ve identified 4 warning signs  with Genetic Analysis (at least 2 which can&#8217;t be ignored)<\/a>, and understanding them should be part of your investment process. <\/p>\n<p>New: Manage All Your Stock Portfolios in One Place<\/p>\n<p>We&#8217;ve created the ultimate portfolio companion for stock investors, and it&#8217;s free.<\/p>\n<p>\u2022 Connect an unlimited number of Portfolios and see your total in one currency<br \/>\u2022 Be alerted to new Warning Signs or Risks via email or mobile<br \/>\u2022 Track the Fair Value of your stocks<\/p>\n<p><a href=\"https:\/\/simplywall.st\/features\/portfolio\" target=\"_blank\" data-focus=\"dashed\" class=\"sc-kuACkN dMOfgv\" rel=\"nofollow noopener\">Try a Demo Portfolio for Free<\/a><\/p>\n<p class=\"sc-8e1a88f-2 fcAAUm\">Have feedback on this article? Concerned about the content? <a href=\"https:\/\/investor-research.typeform.com\/to\/wvg6MFri#feedback_token=NDAyNDM3NTphYmVhMmFmNzIwYWE3OTA2&amp;company=Genetic Analysis&amp;blueprintid=4024375\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Get in touch<\/a> with us directly. Alternatively, email editorial-team (at) simplywallst.com.<\/p>\n<p>This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n","protected":false},"excerpt":{"rendered":"Genetic Analysis (FRA:8V8) Second Quarter 2025 ResultsKey Financial Results Revenue: kr7.15m (up 44% from 2Q 2024). Net loss:&hellip;\n","protected":false},"author":2,"featured_media":119791,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[200,79],"class_list":["post-119790","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetics","tag-genetics","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/119790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=119790"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/119790\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/119791"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=119790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=119790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=119790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}